Here is what happens in most Santa Ana obesity clinical trials:
Prescreening and Screening
Once the research team learns that you wish to participate in an obesity clinical trial, they will call you. A research coordinator will then ask you some questions, including your medical history, to determine whether you meet the inclusion criteria for participation in the research. The procedure is referred to as prescreening. If you pass the prescreening procedure, the research team can schedule a screening appointment to determine if it is medically safe for you to participate in the research.
The initial visit you make as a potential participant is referred to as a screening visit. During the appointment, the research team should provide you with an informed consent form (ICF) that you should read and evaluate. The form contains all the details that the person should understand about the clinical study, including the rationale and objectives of the obesity clinical trial, information about the study, the expected duration of the research, potential risks, and compensation that may be received.
If you choose to engage in the research, after reviewing the consent form, please append your signature. Next, the research team will provide you with a copy of the ICF.
The screening visit also involves meeting with a doctor, who can address your concerns and provide guidance. The doctor will take your height, weight, blood pressure, and temperature. They can also conduct some study-related procedures to verify whether it is safe for you to join the study.
Every clinical study has a screening window, which is the period during which participants receive their results and learn whether they are eligible to participate in the clinical trial. The window’s duration depends on the specific research. If everything goes well, you will return for your enrollment visit. During this visit, the research facility will include you in the study and provide you with the device, medication, or therapy that is part of the study.
Informed Consent
You should decide to participate in the obesity clinical trial willingly, without anyone pressuring you. Whether you suffer from obesity or are healthy, your participation in a clinical study should be informed by your understanding of the clinical research.
The person in charge of communicating the clinical details of the study will explain to you what to expect, outline the objective of the clinical research, describe the potential risks and advantages of participating, and describe the medical interventions being tested. The research team will also explain the tasks participants are required to perform during the clinical study.
Only when participants signal that they have completely understood these research details can they accept or disagree to participate. Participating in clinical trials is always voluntary, and participants can exit the study at any time.